The March 1 conference was a bust. I like how everybody

New Post Public Reply Private Reply Replies (3) Message Board
mariosmack
663
The March 1 conference was a bust. I like how everybody was talking about how OWCP would explode after, but the exact opposite happened.

The anticipation leading up to the conference cause it to soar above 3, but then when nothing important was said at the conference, everybody sold.

From now on, every time there is a conference scheduled and you own shares, watch the numbers leading up. If anticipation causes it to go up, sell right before the conference. If it is stale the days before the conference, then you hold and if it goes up on the day after the conference, sell at the first opportunity. I bought at 1.30, sold at 1.49 day after 3/20 conference, then bought back at 1.26.

Seriously, people, watch the Investor Hangout, Investor Palace and Claytrader videos on OWCP and trade smart.
1

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Be advised that if someone attacks me, that post is not removed, but my response will always be removed. These mods are not unbiased, especially 1, so I have to be extra careful.

Here is what happens when the mods are against me: if I make even 1 mistake, the admins will uphold the deletion by the mods, but if someone attacks me, violating pretty much every rule, then a simple mod refusal to delete is enough and the admins do not get involved.

Also, I am the only person who does not get enraged at others' posts, mostly because I am unbiased. I am in search of the truth. Those who abuse the most have huge stakes in the company and therefore want to silence those who disagree with them
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

NVIDIA Announces Details for Upcoming Q3 Financial Call

Updated Category News Views 84

NVIDIA's Conference Call for Third-Quarter Financial Results NVIDIA is preparing to host a conference call where the company's financial results for the third quarter will be addressed. This call is scheduled for Wednesday, November 20, at 2 p.m. PT, allowing both analysts and investors an opportunity to understand the company's performance in a detailed manner. Live...

Continue Reading
Endeavour Mining's Recent Share Buyback and Market Position

Updated Category News Views 165

Endeavour Mining Conducts Share Buyback Endeavour Mining plc, a leading gold producer, has recently undertaken a strategic initiative by purchasing its own shares in the market. This move signifies a strong commitment to enhancing shareholder value and reflects the company’s robust financial posture. Overview of the Shares Purchased The company acquired a total of...

Continue Reading
Embark on Luxurious Train Journeys Across China’s Landscapes

Updated Category News Views 116

Unveiling the Train of Glamour Experience Journey Beyond the Ordinary: The Train is The Destination Welcome aboard the Train of Glamour, a luxurious travel experience that redefines railway tourism in China. With an expanded route schedule in 2025, the Train of Glamour offers travelers a unique opportunity to explore breathtaking Chinese landscapes and diverse cultures....

Continue Reading
Important Alert for Flywire Investors Amid Legal Proceedings

Updated Category News Views 142

Critical Information for Flywire Corporation Investors If you have invested in Flywire Corporation (NASDAQ: FLYW) and experienced financial losses, it’s essential to pay attention to the upcoming deadline for a class action lawsuit. The Law Offices of Frank R. Cruz is reaching out to inform you of your rights regarding your investment losses and the ongoing litigation...

Continue Reading
Exploring Promising Biotech Stocks for Future Growth Opportunities

Updated Category News Views 94

Innovating in Biotechnology: A Bright Future Ahead The biotechnology sector is witnessing a remarkable transformation, largely fueled by advancements in artificial intelligence (AI). Companies are now leveraging machine learning to effectively identify drug targets, enhance molecular structures, and make accurate predictions regarding clinical trial outcomes. This...

Continue Reading